BridgeBio Oncology Therapeutics
The Director Clinical Scientist leads the medical and scientific aspects of early-phase oncology clinical studies, focusing on first-in-human and Phase 1 programs for RAS- and PI3K-driven solid tumors. This role involves collaborating with multidisciplinary teams to design, implement, and monitor clinical trials while ensuring compliance with regulatory guidelines. The position requires translating preclinical findings into clinical development strategies and serving as a primary medical point of contact for investigators and study teams.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for BridgeBio Oncology Therapeutics.
8% above the average for this role
Clinical Research Associate II
ICON plc
Scientist III, Clinical Regulatory Writing
Cardinal Health
Clinical Development Medical Director- Pain
Vertex
Medical Director, Clinical Development, Oncology (Prostate and Renal Cancers)
Regeneron Pharmaceuticals
Senior Medical Director, Oncology Early Development
AbbVie
Clinical Research Associate II
AbbVie